Ulcerative colitis and its correlation with the incidence of colorectal cancer


Felix Ongko
Erwin Kurniawan Santosa
Edward Then
Lucky Anthonny Setiawan
Vivian Ongriana


The purpose of this research to further reviewed the pathogenesis, risk factors, screening, and preventive interventions for colorectal cancer associated with ulcerative colitis.  The research method used descriptive qualitative through the Literature Review (LR) approach. The data source used a secondary source. Data analysis technique selects literature based on title, year, and indexed articles, then reviews articles that match the subject matter. A literature search was performed using databases, such as PubMed, Cochrane Library, and Science Direct. Colitis-associated neoplasia is thought to result from chronic inflammation, which induces changes in epithelial proliferation, survival, and migration through the effects of various chemokines and cytokines. The risk factors are in three main categories: disease-related, patient-related, and pathology-related. The most reliable screening test is colonoscopy, parallel with a structured endoscopic surveillance program that includes ongoing medical management for disease control. There are several chemopreventive options for the early prevention of colorectal cancer in cases of ulcerative colitis.   In general, long-standing chronic inflammation in the intestinal mucosa increases the risk of colorectal cancer due to genetic and molecular alterations. Identifying high-risk groups and colonoscopic surveillance programs have been considered useful early detection measures.


How to Cite
Ongko, F., Kurniawan Santosa, E., Then, E., Anthonny Setiawan, L. and Ongriana, V. (2023) “Ulcerative colitis and its correlation with the incidence of colorectal cancer”, Science Midwifery, 11(1), pp. 165-173. doi: 10.35335/midwifery.v11i1.1207.


Axelrad, J. E., Faye, A., Slaughter, J. C., Harpaz, N., Itzkowitz, S. H., & Shah, S. C. (2022). Colorectal Strictures in Patients With Inflammatory Bowel Disease Do Not Independently Predict Colorectal Neoplasia. Inflammatory Bowel Diseases, 28(6), 855–861. https://doi.org/10.1093/ibd/izab177
Azuara, D., Rodriguez-Moranta, F., De Oca, J., Sanjuan, X., Guardiola, J., Lobaton, T., Wang, A., Boadas, J., Piqueras, M., Monfort, D., Galter, S., Esteller, M., Moreno, V., & Capellá, G. (2013). Novel methylation panel for the early detection of neoplasia in high-risk ulcerative colitis and Crohn’s colitis patients. Inflammatory Bowel Diseases, 19(1), 165–173. https://doi.org/10.1002/ibd.22994
Bopanna, S., Ananthakrishnan, A. N., Kedia, S., Yajnik, V., & Ahuja, V. (2017). Risk of colorectal cancer in Asian patients with ulcerative colitis: a systematic review and meta-analysis. The Lancet Gastroenterology and Hepatology, 2(4), 269–276. https://doi.org/10.1016/S2468-1253(17)30004-3
Bye, W. A., Ma, C., Nguyen, T. M., Parker, C. E., Jairath, V., & East, J. E. (2018). Strategies for detecting colorectal cancer in patients with inflammatory bowel disease: A cochrane systematic review and meta-analysis. American Journal of Gastroenterology, 113(12), 1801–1809. https://doi.org/10.1038/s41395-018-0354-7
Choi, C. H. R., Al Bakir, I., Ding, N. S. J., Lee, G. H., Askari, A., Warusavitarne, J., Moorghen, M., Humphries, A., Ignjatovic-Wilson, A., Thomas-Gibson, S., Saunders, B. P., Rutter, M. D., Graham, T. A., & Hart, A. L. (2019). Cumulative burden of inflammation predicts colorectal neoplasia risk in ulcerative colitis: A large single-centre study. Gut, 68(3), 414–422. https://doi.org/10.1136/gutjnl-2017-314190
Choi, C. H. R., Bakir, I. Al, Hart, A. L., & Graham, T. A. (2017). Clonal evolution of colorectal cancer in IBD. Nature Reviews Gastroenterology and Hepatology, 14(4), 218–229. https://doi.org/10.1038/nrgastro.2017.1
Choi, C. H. R., Rutter, M. D., Askari, A., Lee, G. H., Warusavitarne, J., Moorghen, M., Thomas-Gibson, S., Saunders, B. P., Graham, T. A., & Hart, A. L. (2015). Forty-year analysis of colonoscopic surveillance program for neoplasia in ulcerative colitis: An updated overview. American Journal of Gastroenterology, 110(7), 1022–1034. https://doi.org/10.1038/ajg.2015.65
Choi, J. kyu, Kim, D. W., Shin, S. Y., Park, E. C., & Kang, J. G. (2016). Effect of ulcerative colitis on incidence of colorectal cancer: Results from the nationwide population-based cohort study (2003-2013). Journal of Cancer, 7(6), 681–686. https://doi.org/10.7150/jca.14264
de Campos Silva, E. F., Baima, J. P., de Barros, J. R., Tanni, S. E., Schreck, T., Saad-Hossne, R., & Sassaki, L. Y. (2020). Risk factors for ulcerative colitis-associated colorectal cancer: A retrospective cohort study. Medicine, 99(32), e21686. https://doi.org/10.1097/MD.0000000000021686
Dulai, P. S., Sandborn, W. J., & Gupta, S. (2016). Colorectal cancer and dysplasia in inflammatory bowel disease: A review of disease Epidemiology, Pathophysiology, and Management. Cancer Prevention Research, 9(12), 887–894. https://doi.org/10.1158/1940-6207.CAPR-16-0124
Fisher, D. A., Princic, N., Miller-Wilson, L. A., Wilson, K., Fendrick, A. M., & Limburg, P. (2021). Utilization of a Colorectal Cancer Screening Test among Individuals with Average Risk. JAMA Network Open, 4(9). https://doi.org/10.1001/jamanetworkopen.2021.22269
Frick, A., Khare, V., Paul, G., Lang, M., Ferk, F., Knasmüller, S., Beer, A., Oberhuber, G., & Gasche, C. (2018). Overt increase of oxidative stress and DNA damage in murine and human colitis and colitis-associated neoplasia. Molecular Cancer Research, 16(4), 634–642. https://doi.org/10.1158/1541-7786.MCR-17-0451
Fumery, M., Dulai, P. S., Gupta, S., Prokop, L. J., Ramamoorthy, S., Sandborn, W. J., & Singh, S. (2017). Incidence, Risk Factors, and Outcomes of Colorectal Cancer in Patients With Ulcerative Colitis With Low-Grade Dysplasia: A Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology, 15(5), 665-674.e5. https://doi.org/10.1016/j.cgh.2016.11.025
Gong, J., Zhu, L., Guo, Z., Li, Y., Zhu, W., Li, N., & Li, J. (2013). Use of thiopurines and risk of colorectal neoplasia in patients with inflammatory bowel diseases: A meta-analysis. PLoS ONE, 8(11). https://doi.org/10.1371/journal.pone.0081487
Gordillo, J., Cabré, E., Garcia-Planella, E., Ricart, E., Ber-Nieto, Y., Márquez, L., Rodríguez-Moranta, F., Ponferrada, Á., Vera, I., Gisbert, J. P., Barrio, J., Esteve, M., Merino, O., Muñoz, F., & Domènech, E. (2015). Thiopurine Therapy Reduces the Incidence of Colorectal Neoplasia in Patients with Ulcerative Colitis. Data from the ENEIDA Registry. Journal of Crohn’s & colitis, 9(12), 1063–1070. https://doi.org/10.1093/ecco-jcc/jjv145
Hata, K., Anzai, H., Ikeuchi, H., Futami, K., Fukushima, K., Sugita, A., Uchino, M., Higashi, D., Itabashi, M., Watanabe, K., Koganei, K., Araki, T., Kimura, H., Mizushima, T., Ueda, T., Ishihara, S., & Suzuki, Y. (2019). Surveillance Colonoscopy for Ulcerative Colitis-Associated Colorectal Cancer Offers Better Overall Survival in Real-World Surgically Resected Cases. American Journal of Gastroenterology, 114(3), 483–489. https://doi.org/10.14309/ajg.0000000000000117
Jess, T., Lopez, A., Andersson, M., Beaugerie, L., & Peyrin-Biroulet, L. (2014). Thiopurines and Risk of Colorectal Neoplasia in Patients With Inflammatory Bowel Disease: A Meta-analysis. Clinical Gastroenterology and Hepatology, 12(11), 1793-1800.e1. https://doi.org/10.1016/j.cgh.2014.05.019
Jess, T., Simonsen, J., Jorgensen, K. T., Pedersen, B. V., Nielsen, N. M., & Frisch, M. (2012). Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years. Gastroenterology, 143(2), 375-381.e1. https://doi.org/10.1053/j.gastro.2012.04.016
Jong, M. E., Gillis, V. E. L. M., Derikx, L. A. A. P., & Hoentjen, F. (2020). No increased risk of colorectal neoplasia in patients with inflammatory bowel disease and postinflammatory polyps. Inflammatory Bowel Diseases, 26(9), 1383–1389. https://doi.org/10.1093/ibd/izz261
Kisiel, J. B., & Ahlquist, D. A. (2013). Stool DNA testing for cancer surveillance in inflammatory bowel disease: An early view. Therapeutic Advances in Gastroenterology, 6(5), 371–380. https://doi.org/10.1177/1756283X13487941
Kucharzik, T., Ellul, P., Greuter, T., Rahier, J. F., Verstockt, B., Abreu, C., Albuquerque, A., Allocca, M., Esteve, M., Farraye, F. A., Gordon, H., Karmiris, K., Kopylov, U., Kirchgesner, J., Macmahon, E., Magro, F., Maaser, C., De Ridder, L., Taxonera, C., … Vavricka, S. (2021). ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease. Journal of Crohn’s and Colitis, 15(6), 879–913. https://doi.org/10.1093/ecco-jcc/jjab052
Li, W., Zhao, T., Wu, D., Li, J., Wang, M., Sun, Y., & Hou, S. (2022). Colorectal Cancer in Ulcerative Colitis: Mechanisms, Surveillance and Chemoprevention. Current Oncology, 29(9), 6091–6114. https://doi.org/10.3390/curroncol29090479
Lopez, A., Pouillon, L., Beaugerie, L., Danese, S., & Peyrin-Biroulet, L. (2018). Colorectal cancer prevention in patients with ulcerative colitis. Best Practice and Research: Clinical Gastroenterology, 32–33, 103–109. https://doi.org/10.1016/j.bpg.2018.05.010
Lu, M. J., Qiu, X. Y., Mao, X. Q., Li, X. T., & Zhang, H. J. (2018). Systematic review with meta-analysis: thiopurines decrease the risk of colorectal neoplasia in patients with inflammatory bowel disease. Alimentary Pharmacology and Therapeutics, 47(3), 318–331. https://doi.org/10.1111/apt.14436
Luo, C., & Zhang, H. (2017). The Role of Proinflammatory Pathways in the Pathogenesis of Colitis-Associated Colorectal Cancer. Mediators of Inflammation, 2017. https://doi.org/10.1155/2017/5126048
Lutgens, M. W. M. D., van Oijen, M. G. H., van der Heijden, G. J. M. G., Vleggaar, F. P., Siersema, P. D., & Oldenburg, B. (2013). Declining risk of colorectal cancer in inflammatory bowel disease: an updated meta-analysis of population-based cohort studies. Inflammatory bowel diseases, 19(4), 789–799. https://doi.org/10.1097/MIB.0b013e31828029c0
Magro, F., Gionchetti, P., Eliakim, R., Ardizzone, S., Armuzzi, A., Barreiro-de Acosta, M., Burisch, J., Gecse, K. B., Hart, A. L., Hindryckx, P., Langner, C., Limdi, J. K., Pellino, G., Zagórowicz, E., Raine, T., Harbord, M., & Rieder, F. (2017). Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: Definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders. Journal of Crohn’s and Colitis, 11(6), 649–670. https://doi.org/10.1093/ecco-jcc/jjx008
Pasternak, B., Svanström, H., Schmiegelow, K., Jess, T., & Hviid, A. (2013). Use of azathioprine and the risk of cancer in inflammatory bowel disease. American Journal of Epidemiology, 177(11), 1296–1305. https://doi.org/10.1093/aje/kws375
Pereira, C., Grácio, D., Teixeira, J. P., & Magro, F. (2015). Oxidative Stress and DNA Damage: Implications in Inflammatory Bowel Disease. Inflammatory Bowel Diseases, 21(10), 2403–2417. https://doi.org/10.1097/MIB.0000000000000506
Rennoll, S. (2015). Regulation of MYC gene expression by aberrant Wnt/β-catenin signaling in colorectal cancer . World Journal of Biological Chemistry, 6(4), 290. https://doi.org/10.4331/wjbc.v6.i4.290
Reznicek, E., Arfeen, M., Shen, B., & Ghouri, Y. (2021). Colorectal Dysplasia and Cancer Surveillance in Ulcerative Colitis. Diseases, 9(4), 86. https://doi.org/10.3390/diseases9040086
Robles, A. I., Traverso, G., Zhang, M., Roberts, N. J., Khan, M. A., Joseph, C., Lauwers, G. Y., Selaru, F. M., Popoli, M., Pittman, M. E., Ke, X., Hruban, R. H., Meltzer, S. J., Kinzler, K. W., Vogelstein, B., Harris, C. C., & Papadopoulos, N. (2016). Whole-Exome Sequencing Analyses of Inflammatory Bowel Disease-Associated Colorectal Cancers. Gastroenterology, 150(4), 931–943. https://doi.org/10.1053/j.gastro.2015.12.036
Rubin, D. T., Ananthakrishnan, A. N., Siegel, C. A., Sauer, B. G., & Long, M. D. (2019). ACG Clinical Guideline: Ulcerative Colitis in Adults. American Journal of Gastroenterology, 114(3), 384–413. https://doi.org/10.14309/ajg.0000000000000152
Samadder, N. J., Valentine, J. F., Guthery, S., Singh, H., Bernstein, C. N., Leighton, J. A., Wan, Y., Wong, J., Boucher, K., Pappas, L., Rowe, K., Burt, R. W., Curtin, K., & Smith, K. R. (2019). Family History Associates With Increased Risk of Colorectal Cancer in Patients With Inflammatory Bowel Diseases. Clinical Gastroenterology and Hepatology, 17(9), 1807-1813.e1. https://doi.org/10.1016/j.cgh.2018.09.038
Saraggi, D., Fassan, M., Mescoli, C., Scarpa, M., Valeri, N., Michielan, A., D’Incá, R., & Rugge, M. (2017). The molecular landscape of colitis-associated carcinogenesis. Digestive and Liver Disease, 49(4), 326–330. https://doi.org/10.1016/j.dld.2016.12.011
Scarpa, M., Castagliuolo, I., Castoro, C., Pozza, A., Scarpa, M., Kotsafti, A., & Angriman, I. (2014). Inflammatory colonic carcinogenesis: A review on pathogenesis and immunosurveillance mechanisms in ulcerative colitis. World Journal of Gastroenterology, 20(22), 6774–6785. https://doi.org/10.3748/wjg.v20.i22.6774
Selinger, C. P., Andrews, J. M., Titman, A., Norton, I., Jones, D. B., McDonald, C., Barr, G., Selby, W., Leong, R., Andrews, J., Barnes, P., Barr, G., Bye, W., Chapman, G., Cowlishaw, J., Gallagher, N., Gillies, M., Goulston, K., Goulston, S., … Selby, W. (2014). Long-term Follow-up Reveals Low Incidence of Colorectal Cancer, but Frequent Need for Resection, Among Australian Patients With Inflammatory Bowel Disease. Clinical Gastroenterology and Hepatology, 12(4), 644–650. https://doi.org/10.1016/j.cgh.2013.05.017
Shah, S. C., & Itzkowitz, S. H. (2022). Colorectal Cancer in Inflammatory Bowel Disease: Mechanisms and Management. Gastroenterology, 162(3), 715-730.e3. https://doi.org/10.1053/j.gastro.2021.10.035
Siegel, R., Naishadham, D., & Jemal, A. (2012). CA: A Cancer Journal for Clinicians. CA: A Cancer Journal for Clinicians, 62(1), 10–29. https://doi.org/10.3322/caac.20138
Söderlund, S., Granath, F., Broström, O., Karlén, P., Löfberg, R., Ekbom, A., & Askling, J. (2010). Inflammatory Bowel Disease Confers a Lower Risk of Colorectal Cancer to Females Than to Males. Gastroenterology, 138(5). https://doi.org/10.1053/j.gastro.2010.02.007
Takehiro, H., Daisuke, H., Kohei, W., Tsukasa, Y., Yoshihiro, Y., & Hiroshi, N. (2020). Immunological mechanisms in Inflammation-Associated Colon carcinogenesis. International Journal of Molecular Sciences, 21, 3062.
Waldner, M. J., & Neurath, M. F. (2015). Mechanisms of Immune Signaling in Colitis-Associated Cancer. Cmgh, 1(1), 6–16. https://doi.org/10.1016/j.jcmgh.2014.11.006
Wijnands, A. M., de Jong, M. E., Lutgens, M. W. M. D., Hoentjen, F., Elias, S. G., & Oldenburg, B. (2021). Prognostic Factors for Advanced Colorectal Neoplasia in Inflammatory Bowel Disease: Systematic Review and Meta-analysis. Gastroenterology, 160(5), 1584–1598. https://doi.org/10.1053/j.gastro.2020.12.036
Yvellez, O. V., Rai, V., Sossenheimer, P. H., Hart, J., Turner, J. R., Weber, C., El Jurdi, K., & Rubin, D. T. (2021). Cumulative Histologic Inflammation Predicts Colorectal Neoplasia in Ulcerative Colitis: A Validation Study. Inflammatory Bowel Diseases, 27(2), 203–206. https://doi.org/10.1093/ibd/izaa047